Climate Change Worsens Most Infectious Diseases

Of the pathogens known to have infected humans, more than half may cause more widespread disease as a result of rising temperatures, precipitation changes, or other climate-related factors, a study finds.

Written byAndy Carstens
| 2 min read
Mosquitos flying at sunset
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The consequences of climate change—including warming, drought, and sea-level rise—worsen most infectious diseases by facilitating transmission and increasing the severity of outbreaks, according to a study published today (August 8) in Nature Climate Change. The study finds that climate change has the potential to exacerbate outbreaks of 58 percent of the 375 pathogens that have infected humans in recorded history.

“Systems have been evolving for millions of years and now humans have come along and changed things,” study coauthor Camilo Mora at the University of Hawai‘i at Mānoa tells NBC News, adding that “we are punching nature, but nature is punching us back.”

To assess the impact of greenhouse gas emissions on disease, Mora and his colleagues analyzed more than 3,200 published scientific works, identifying outbreaks reported as having been intensified by at least one climate hazard, such as drought. Tallying the pathogens that cropped up in that evaluation, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Andrew Carstens

    Andy Carstens is a freelance science journalist who is a current contributor and past intern at The Scientist. He has a bachelor’s degree in chemical engineering from the Georgia Institute of Technology and a master’s in science writing from Johns Hopkins University. Andy’s work has previously appeared in AudubonSlateThem, and Aidsmap. View his full portfolio at www.andycarstens.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies